| Identification | Back Directory | [Name]
Enzaplatovir | [CAS]
1323077-89-9 | [Synonyms]
BTA-585
BTA-C585)
Enzaplatovir
Enzaplatovir
(BTA585
Enzaplatovir（BTA-C585） | [Molecular Formula]
C20H19N5O3 | [MDL Number]
MFCD34469174 | [MOL File]
1323077-89-9.mol | [Molecular Weight]
377.4 |
| Chemical Properties | Back Directory | [Boiling point ]
663.0±55.0 °C(Predicted) | [density ]
1.46±0.1 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO : 200 mg/mL (529.94 mM; Need ultrasonic) | [form ]
Solid | [pka]
6.08±0.12(Predicted) | [color ]
White to light yellow |
| Hazard Information | Back Directory | [Uses]
Enzaplatovir (BTA-C585) is an orally bioavailable Inhibitor for respiratory syncytial virus (RSV) infection[1]. | [storage]
Store at -20°C | [References]
[1] Eric A F Sim?es, et al. Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children. Infect Dis Ther. 2018 Mar;7(1):87-120. DOI:10.1007/s40121-018-0188-z |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|